Patterns of antidepressant medication use among pregnant women in a United States population.
about
The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approachDrugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risksUse of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and SwedenPrenatal antidepressant exposure: clinical and preclinical findings.Antidepressants may mitigate the effects of prenatal maternal anxiety on infant auditory sensory gating.Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.The mothers, Omega-3 and mental health study.Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot.Is it safe to use smoking cessation therapeutics during pregnancy?Prevalence of antidepressant use during pregnancy in Denmark, a nation-wide cohort studyEarly-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.Mood disorders and their pharmacological treatment during pregnancy: is the future child affected?The effects of antenatal depression and antidepressant treatment on placental gene expression.The National Center on Birth Defects and Developmental Disabilities: past, present, and future.The effects of depression and use of antidepressive medicines during pregnancy on the methylation status of the IGF2 imprinted control regions in the offspring.Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007.Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort studyNeonatal and childhood neurodevelopmental, health and educational outcomes of children exposed to antidepressants and maternal depression during pregnancy: protocol for a retrospective population-based cohort study using linked administrative dataSelective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based InvestigationIs third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage?The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month.In utero exposure to antidepressants and the use of drugs for pulmonary diseases in childrenAntidepressant use during pregnancy: navigating the sea of information.A "bottom-up" approach to aetiological research in autism spectrum disordersAntidepressant exposure in pregnancy and risk of autism spectrum disorders.Maternal Characteristics of Women Exposed to Hypnotic Benzodiazepine Receptor Agonist during Pregnancy.The safety of escitalopram during pregnancy and breastfeeding: a comprehensive review.Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy.Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: a systematic review.Annual Research Review: The role of the environment in the developmental psychopathology of autism spectrum condition.Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence.Prenatal exposure to serotonin reuptake inhibitors and congenital heart anomalies: an exploratory pharmacogenetics study.Prenatal exposure to antidepressants and risk of epilepsy in childhood.Findings from the National Birth Defects Prevention Study: Interpretation and translation for the clinician.Development of a mother-child database for drug exposure and adverse event detection in the Military Health System.
P2860
Q26741187-26394582-D411-42E0-A716-0E96ECDE0292Q26774013-0A878D9E-BC7D-4F03-817D-0878F0A6B9ACQ26991704-D0863AB7-4090-449D-A3F5-CFFCDE0EA082Q28551620-8D3F0506-F022-4F0F-9E3D-7112B7A3F4C0Q30415540-1C662BE8-29EA-493A-82AE-26E3DB6D5E3DQ30453943-38DD8A16-0418-4B64-BB5F-C4BF5463E9A1Q30979346-81F13BEB-F1ED-457B-83CD-ADCCFC6C1790Q33551798-FE631A6F-CD55-4CCB-B45C-62CCB6E3E9B7Q33907544-6047F76D-17F5-4715-931C-B29ECB64DA27Q33940207-0E6E2053-88A1-46BB-A839-E18A60C13609Q34073546-8AFED313-09B1-44E1-BB1D-56408330D9F6Q34270366-E80B52CA-0F9F-4069-978A-4B33BECD0278Q34444221-348EA3B2-1544-45AD-8894-E3E9E6CF3E89Q34702282-8D0582CB-0C8F-43AE-9E82-341E3A200FA5Q34714284-C7D3D893-91BF-4FD5-922B-56A8D8A9119EQ34895532-009D64C6-005F-4597-96A3-B7D14DAD197AQ34936521-CE0AE930-7359-4962-946F-37E1EB821A44Q35653556-623FB8A7-3EF2-4FC2-8692-E2EABB4B6143Q35670663-142E4BA7-7245-4975-9D40-2E4C98A82E6DQ35794715-11A11953-72FC-40DA-82CC-6A54EF21E5FEQ36045075-FE7F4D80-E3D1-45A0-A603-6EF9FE127BF0Q36207250-31E5CC7D-E28D-426E-BA86-CFB3D7EDB817Q36209588-D5D3BF84-0784-49EA-8E45-83EA40A14405Q36225011-F518ACB4-D30E-48C4-AC65-C09A1B699762Q36535314-EBA9B2D0-8F48-4F94-8A5F-0D763FEA681BQ36547279-4A33B1BF-82C8-444D-8C36-25EF4CD32028Q36609764-D881A535-14B6-4DD0-B375-BE959BC5260FQ37167417-B58FD5C2-DF94-4809-ACEF-A1B554EDFA24Q37182313-9D660DE7-1CFE-4EC4-B53A-28FF2CBFFE66Q37320948-5E69439C-4FD4-4088-8B57-5343C4BBFE68Q37730625-6BE578F0-2AFB-4E79-8D85-C24E5E95DEF6Q38050322-7AC4AE05-4E20-458E-BC06-8771B08DE8F1Q38089714-6B1C07B3-30E9-41E7-BBFF-1DE4A4B8A02EQ38215072-5881016F-7730-4E38-8F1D-AC6A6A66E6AAQ38702052-F9A5F352-933F-44DB-A768-ABAB45992535Q38823790-D744CFD1-043E-4B84-AA1F-01472BD09C73Q40149970-4C3186FE-6F2E-489F-96E8-E2BF6D92244FQ40498883-1650E8BA-E2C8-4DFD-AB51-363DCCAE57B1Q40799758-41F45158-7F0F-48D6-A0B4-DA6045501224Q41125596-51E7417D-31FD-4A23-835D-BAAF68DC64F7
P2860
Patterns of antidepressant medication use among pregnant women in a United States population.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Patterns of antidepressant med ...... in a United States population.
@en
Patterns of antidepressant med ...... in a United States population.
@nl
type
label
Patterns of antidepressant med ...... in a United States population.
@en
Patterns of antidepressant med ...... in a United States population.
@nl
prefLabel
Patterns of antidepressant med ...... in a United States population.
@en
Patterns of antidepressant med ...... in a United States population.
@nl
P2860
P50
P356
P1476
Patterns of antidepressant med ...... in a United States population.
@en
P2093
Sura Alwan
P2860
P304
P356
10.1177/0091270010373928
P577
2010-07-27T00:00:00Z